Product Design, Manufacturing & Innovation Resources

최신 논문 – 재생 의학 관련 특허

Regenerative Medicine

팁: 아래 선택 항목 외에도, 저희가 제공하는 두 개의 전체 데이터베이스를 검색하고 필터링할 수 있습니다.

> 무료 간행물 검색 도구 < 저자, 주제, 키워드, 날짜 또는 저널별로 검색.

> 무료 특허 검색 도구 < 유럽 ​​특허청의 영문 특허를 참조하십시오.

Regenerative medicine
재생의학은 줄기세포 생물학, 조직 공학 및 생체 재료를 통합하여 조직 및 장기 복원에 혁신을 가져옵니다.

Regenerative medicine focuses on restoring or replacing damaged tissues and organs through the integration of stem cell biology, tissue engineering, and biomaterials science. This interdisciplinary field employs techniques such as scaffold fabrication, cellular reprogramming, and gene editing to promote tissue regeneration, enhance wound healing, and develop functional organ substitutes. Research addresses cellular differentiation, immunomodulation, vascularization, and extracellular matrix remodeling to optimize therapeutic outcomes. Our page compiles the latest peer-reviewed studies and patented 기술 advancing regenerative strategies, biomaterial innovations, and clinical applications that redefine approaches to tissue repair and organ replacement.

본 자료는 재생의학 분야의 최신 영문 논문 및 특허를 엄선하여 정리한 것으로, 다양한 온라인 과학 저널에 게재된 자료들을 포함하며, 줄기세포, 조직공학, 세포치료, 생체재료, 지지체 제작, 유도만능줄기세포, 재생 지지체, 세포외기질, 장기재생, 3D 바이오프린팅, 성장인자, 중간엽줄기세포, 세포분화, 유전자편집, 상처치유, 재생생체재료, 세포이식, 면역조절, 조직재생, 세포재프로그래밍, 생체활성분자, 혈관형성, 재생치료, 자가세포, 동종세포, 재생이식, 세포증식, 기질재형성, 재생미세환경 등의 주제를 중점적으로 다룹니다.

System for the production of advanced therapy manufactured products (atmps)

Patent published on the 2026-05-28 in WO under Ref WO2026112201 by SEDNA CELL CARE CORP [US] (Figueroa Rogelio [us], Stephens Erin [us], Benedict Michael [us], Gonzalez Arturo [us], Santell Manuel [us])

Abstract: A device and system for the medical processing of advanced therapy medicinal products. The system featuring a processing unit operating with a disposable fluid-container assembly constitutes a fully closed, self-contained manufacturing environment for cell-therapy production — including washing, enrichment, activation, genetic modification, expansion, media exchanges, in-process sampling, formulation, and final harvest of the produced cell therapy products.[...]


Our summary: The system is designed for the production of advanced therapy medicinal products. It includes a processing unit with a disposable fluid-container assembly for a fully closed manufacturing environment. The system supports various processes such as washing, activation, and final harvest of cell therapy products.

advanced therapy, manufacturing system, cell therapy, closed processing

Patent

Compositions and methods for induced stem cell differentiation to oligodendrocytes

Patent published on the 2026-05-28 in WO under Ref WO2026112110 by EXIR INC [US] (Roodgar Morteza [us])

Abstract: A method of differentiating nonhuman primate induced pluripotent stem cells (iPSCs) to oligodendrocytes is provided. The method may include providing a modified vector comprising a piggyBac vector backbone that expresses one or more differentiation factor genes, including SOX10, OLIG2, and NKX6-2. The piggyBac vector backbone may comprise one or more terminal inverted repeats and one or more transposase recognition sites configured to interact with a piggyBac transposase to mediate genomic integ[...]


Our summary: The method describes differentiating nonhuman primate iPSCs into oligodendrocytes using a modified piggyBac vector. This vector expresses key differentiation factors such as SOX10, OLIG2, and NKX6-2. The differentiated cells are identified by specific oligodendrocyte-associated markers.

iPSCs, oligodendrocytes, piggyBac vector, differentiation factors

Patent

Microcavity bioreactors and systems for 3d cell culture

Patent published on the 2026-05-28 in WO under Ref WO2026111867 by CORNING INCORPORATED [US] (Fang Ye [us])

Abstract: A microcavity bioreactor is provided that allows cell growth and cell differentiation in the same vessel, such that higher order three-dimensional cell cultures such as organoids can be generated in a singular vessel. The microcavity bioreactor may be part of a microcavity bioreactor system that allows for perfusion based cell culture and perfusion based cell harvesting. The microcavity bioreactor includes at least one, and preferably at least two, fluid distributor structures in the housing ves[...]


Our summary: Microcavity bioreactors enable simultaneous cell growth and differentiation in a single vessel. They facilitate the generation of higher-order 3D cell cultures like organoids. The system incorporates fluid distributor structures for enhanced perfusion-based culture and harvesting.

microcavity bioreactor, 3D cell culture, organoids, perfusion

Patent

Method of synthesis of testosteronan polymer and derivatives and uses thereof

Patent published on the 2026-05-28 in WO under Ref WO2026112535 by WEKA BIOSCIENCES LLC [US] (Otto Nigel J [us])

Abstract: Embodiments of the present invention provides recombinant systems, methods, and compositions for the biological production of Testosteronan (Testan), a linear α-(1→4)-linked glucuronic acid–N-acetylglucosamine polysaccharide. Microbial hosts engineered to express full-length CtTS, N-terminal truncation variants (including d64-CtTS), or the Pseudomonas CIPTS homolog synthesize high–molecular-weight Testan (≥800 kDa) with low polydispersity. Structural analysis by ¹H NMR and 2D HSQC demo[...]


Our summary: The invention details a method for synthesizing Testosteronan (Testan) using engineered microbial hosts. It includes purification techniques to obtain defined molecular-weight fractions and sulfated derivatives. Additionally, it outlines applications for Testan in chromatographic stationary phases and biomaterial scaffolds.

Testosteronan, microbial synthesis, polysaccharide derivatives, chromatographic applications

Patent

Identification and validation of fetal hemogobin-induction by idasanutlin for the treatment of sickle cell disease

Patent published on the 2026-05-28 in WO under Ref WO2026107592 by NARENDRAN ARUMUGAVADIVEL [CA] (Narendran Arumugavadivel [ca], Sipila Patrick [ca], Thakur Satbir [ca])

Abstract: The present application relates to the use of idasanutlin, or a pharmaceutically acceptable salt, a solvate, an isomer, or a functional derivative thereof for the treatment of hemoglobinopathies, including sickle cell disease, thalassemia, sickle cell beta thalassemia (Hb S/β Th), and leukocytosis as well as myeloproliferative conditions, polycythemia, and acute and chronic hemolytic anemia. It was found that idasanutlin increases HbF levels in multipotent erythroleukemia, hematopoietic stem ce[...]


Our summary: Idasanutlin is used to treat sickle cell disease and other hemoglobinopathies. It increases fetal hemoglobin (HbF) levels in relevant cell types. This provides a potential new therapy for managing sickle cell disease.

Idasanutlin, fetal hemoglobin, sickle cell disease, hemoglobinopathies

Patent

Method for producing cultured meat, and cultured meat

Patent published on the 2026-05-21 in WO under Ref WO2026105820 by ITOHAM YONEKYU HOLDINGS INC [JP] (Matsusaki Michiya [jp], Yamada Asuka [jp], Nakadozono Oya Chika [jp], Sugiura Takuya [jp], Takasuga Akiko [jp])

Abstract: The present disclosure relates to a method for producing cultured meat, the method comprising: a washing step for bringing bovine tissue into contact with a washing liquid containing peracetic acid; a recovery step for recovering stem cells from the washed bovine tissue; a preparation step for preparing bio-ink containing the recovered stem cells and fragmented extracellular matrix components; a printing step for printing the bio-ink to form a structure containing the stem cells; and a culturing[...]


Our summary: The method involves washing bovine tissue with peracetic acid, recovering stem cells, and preparing a bio-ink. The bio-ink is printed to create a structure containing stem cells. Finally, the stem cells undergo differentiation induction culturing to form a tissue body.

cultured meat, stem cells, bio-ink, tissue engineering

Patent

Joint material and shape optimization of a 3D printing nozzle by CFD and response surface methodology

Published on 2026-03-12 by @OXFORD

Abstract: AbstractThree-dimensional printing (3D printing) has emerged as a transformative technology in medicine, enabling the fabrication of complex structures with high precision. In bioprinting, optimization of nozzle design is essential to balance print resolution, mechanical strength, and biocompatibility. This study presents a computational framework for optimizing bioprinting performance by simultaneously accounting for nozzle geometry and biomaterial rheological properties. Using computational fl[...]


Our summary: This study presents a computational framework for optimizing bioprinting by integrating nozzle geometry and biomaterial properties. It utilizes CFD and response surface methodology to identify optimal nozzle configurations. Results show significant improvements in flow rate and reductions in wall shear stress, demonstrating the effectiveness of the approach.

3D printing, nozzle optimization, computational fluid dynamics, response surface methodology

Publication

Mechanisms, Effects, and Applications

Published on 2026-02-03 by Maryam Dastan, Ellen Dyminski Parente Ribeiro, Ursula Bellut-Staeck, Juan Zhou, Christian Lehmann @MDPI

Abstract: Infrasound, physically defined as sound at frequencies below 20 Hertz, can travel long distances with minimal attenuation and permeate biological tissues due to its marked particle displacement and deep penetration. Generated by both natural phenomena and human-made systems, infrasound has drawn increasing scientific and public attention regarding its potential physiological and psychological effects. Experimental studies demonstrate that infrasound can modulate mechanosensitive structures at th[...]


Our summary: Infrasound is sound below 20 Hertz that can penetrate biological tissues. It has both harmful and beneficial effects depending on intensity and frequency. Future research is needed to standardize exposure metrics and clarify health risks and therapeutic applications.

Infrasound, physiological effects, mechanosensitive structures, exposure assessment

Publication

다룬 주제: 재생의학, 줄기세포생물학, 조직공학, 생체재료, 지지체 제작, 세포 재프로그래밍, 유전자 편집, 조직 재생, 상처 치유, 장기 대체물, 세포 분화, 면역 조절, 혈관 형성, 세포외 기질 재구성, 치료 결과, 동료 심사 연구, 임상 응용, ISO 13485, ISO 14971, ASTM F2633, ISO 10993 및 ISO 14644.

역사적 맥락

1965
1970
1980
1980
1990
1960
1969
1976-05-28
1980
1990

(날짜를 알 수 없거나 관련이 없는 경우, 예를 들어 "유체역학"의 경우, 주목할 만한 등장 시기를 대략적으로 추정하여 제공합니다.)

고화질 이미지 및 다운로드는 등록된 회원에게만 100% 무료로 제공됩니다.

> 로그인 <